Ascendis Pharma A/S (ASND)
NASDAQ: ASND · Real-Time Price · USD
218.82
-5.29 (-2.36%)
At close: Jun 1, 2026, 4:00 PM EDT
219.70
+0.88 (0.40%)
After-hours: Jun 1, 2026, 5:04 PM EDT
Ascendis Pharma Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst J.P. Morgan No rating | J.P. Morgan | Buy Maintains $295 | Buy | Maintains | $295 | +34.81% | May 20, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $256 → $241 | Buy | Maintains | $256 → $241 | +9.91% | May 18, 2026 |
| Evercore ISI | Evercore ISI | Buy Reiterates $324 → $329 | Buy | Reiterates | $324 → $329 | +50.35% | May 15, 2026 |
Unknown Analyst Citi No rating | Citi | Buy Initiates $355 | Buy | Initiates | $355 | +62.23% | May 15, 2026 |
| Barclays | Barclays | Buy Reiterates $342 → $345 | Buy | Reiterates | $342 → $345 | +57.66% | May 11, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $275 | Buy | Maintains | $275 | +25.67% | May 8, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $330 → $326 | Buy | Maintains | $330 → $326 | +48.98% | May 8, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $292 → $288 | Buy | Reiterates | $292 → $288 | +31.62% | May 8, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.